Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study
DA Mahler, M Decramer, A D'Urzo… - European …, 2014 - Eur Respiratory Soc
We evaluated the effect of QVA149, a dual bronchodilator combining indacaterol and
glycopyrronium, on direct patient-reported dyspnoea in patients with moderate-to-severe …
glycopyrronium, on direct patient-reported dyspnoea in patients with moderate-to-severe …
[引用][C] Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study
DA MAHLER, M DECRAMER… - The European …, 2014 - pascal-francis.inist.fr
Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE
study CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
study CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study
DA Mahler, M Decramer, A D'Urzo, H Worth, T White… - 2014 - pubmed.ncbi.nlm.nih.gov
We evaluated the effect of QVA149, a dual bronchodilator combining indacaterol and
glycopyrronium, on direct patient-reported dyspnoea in patients with moderate-to-severe …
glycopyrronium, on direct patient-reported dyspnoea in patients with moderate-to-severe …
Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: BLAZE study
DA Mahler, M Decramer, A D'Urzo… - European …, 2013 - Eur Respiratory Soc
We evaluated the effect of QVA149, a dual bronchodilator combining indacaterol and
glycopyrronium, on direct patient-reported dyspnoea in patients with moderate-to-severe …
glycopyrronium, on direct patient-reported dyspnoea in patients with moderate-to-severe …
[引用][C] Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study
DA Mahler, M Decramer, A D'Urzo, H Worth… - European Respiratory …, 2013 - cir.nii.ac.jp
[PDF][PDF] Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study
DA Mahler, M Decramer, A D'Urzo, H Worth, T White… - 2014 - qdcxjkg.com
We evaluated the effect of QVA149, a dual bronchodilator combining indacaterol and
glycopyrronium, on direct patient-reported dyspnoea in patients with moderate-to-severe …
glycopyrronium, on direct patient-reported dyspnoea in patients with moderate-to-severe …
[PDF][PDF] Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: BLAZE study
DA Mahler, M Decramer, A D'Urzo, H Worth, T White… - 2013 - Citeseer
Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: BLAZE study
Page 1 1 Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: BLAZE …
Page 1 1 Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: BLAZE …
Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study.
DA Mahler, M Decramer, A D'Urzo, H Worth… - The European …, 2013 - europepmc.org
We evaluated the effect of QVA149, a dual bronchodilator combining indacaterol and
glycopyrronium, on direct patient-reported dyspnoea in patients with moderate-to-severe …
glycopyrronium, on direct patient-reported dyspnoea in patients with moderate-to-severe …
[PDF][PDF] Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study
DA Mahler, M Decramer, A D'Urzo, H Worth, T White… - 2014 - qdcxjkg.com
We evaluated the effect of QVA149, a dual bronchodilator combining indacaterol and
glycopyrronium, on direct patient-reported dyspnoea in patients with moderate-to-severe …
glycopyrronium, on direct patient-reported dyspnoea in patients with moderate-to-severe …
[PDF][PDF] Dual bronchodilation with QVA149 reduces patient-reported dyspnoea in COPD: the BLAZE study
DA Mahler, M Decramer, A D'Urzo, H Worth, T White… - 2014 - Citeseer
We evaluated the effect of QVA149, a dual bronchodilator combining indacaterol and
glycopyrronium, on direct patient-reported dyspnoea in patients with moderate-to-severe …
glycopyrronium, on direct patient-reported dyspnoea in patients with moderate-to-severe …